-+ 0.00%
-+ 0.00%
-+ 0.00%

Dogwood Therapeutics Advances Halneuron Phase 2b Trial and Expands Pipeline for Cancer-Related Pain Therapies

Reuters·01/20/2026 13:31:44

Please log in to view news